Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
0.960
-0.017 (-1.73%)
Nov 21, 2024, 10:08 AM EST - Market open
Femasys Employees
As of December 31, 2023, Femasys had 34 total employees, including 32 full-time and 2 part-time employees. The number of employees decreased by 2 or -5.56% compared to the previous year.
Employees
34
Change (1Y)
-2
Growth (1Y)
-5.56%
Revenue / Employee
$37,078
Profits / Employee
-$532,453
Market Cap
21.35M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 34 | -2 | -5.56% |
Dec 31, 2022 | 36 | 7 | 24.14% |
Dec 31, 2021 | 29 | 3 | 11.54% |
Dec 31, 2020 | 26 | 0 | - |
Dec 31, 2019 | 26 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Bolt Biotherapeutics | 100 |
Spectral AI | 78 |
Pieris Pharmaceuticals | 50 |
GlycoMimetics | 35 |
NeuroOne Medical Technologies | 16 |
BriaCell Therapeutics | 16 |
AEON Biopharma | 10 |
XTL Biopharmaceuticals | 7 |
FEMY News
- 9 days ago - Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update - GlobeNewsWire
- 20 days ago - Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control - GlobeNewsWire
- 6 weeks ago - Femasys to Exhibit at ASRM 2024 and Participate in the Congress' KEEPR Education Program - GlobeNewsWire
- 7 weeks ago - Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments - GlobeNewsWire
- 2 months ago - Femasys Announces Infertility Clinic Customers from Coast to Coast - GlobeNewsWire
- 2 months ago - Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market - GlobeNewsWire
- 2 months ago - Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check - GlobeNewsWire
- 2 months ago - Femasys to Exhibit at The Canadian Fertility and Andrology Society's 70th Annual Meeting - GlobeNewsWire